Key result
Radiofrequency energy treatment significantly improved heartburn and GERD-specific quality of life scores at 48 months in 92.8% of patients, with 72.3% completely off PPIs.
Why the study?
Does radiofrequency energy delivery improve symptoms and quality of life in patients with GERD?
Cohort (n=69)
Does radiofrequency energy delivery improve symptoms and quality of life in patients with GERD?
Answers are grounded in this paper and cite their sources.
Radiofrequency energy delivery to the lower esophageal sphincter provides durable symptom relief and reduces PPI use in selected GERD patients over 48 months.
Since 2000, radiofrequency (RF) energy treatment has been increasingly offered as an alternative option to invasive surgical procedures for selected patients with gastroesophageal reflux disease (GERD). Out of 69 patients treated since June 2002 to December 2007 with the Stretta procedure, 56 of them reached by the end of 2010 a 48-month followup. RF treatment significantly improved heartburn scores, GERD-specific quality of life scores, and general quality of life scores at 24 and 48 months in 52 out of 56 patients (92,8%). At each control time both mean heartburn and GERD HRQL scores decreased (P = 0.001 and P = 0.003, resp.) and both mental SF-36 and physical SF-36 ameliorated (P = 0.001 and 0.05, resp.). At 48 months, 41 out of 56 patients (72,3%) were completely off PPIs. Morbidity was minimal, with only one relevant but transient complication. According to other literature data, this study shows that RF delivery to LES is safe and durably improves symptoms and quality of life in well-selected GERD patients.
No takes yet. Share an insight, caveat, or question.
Dughera et al. (2011) conducted a cohort in Gastroesophageal reflux disease (GERD) (n=69). Radiofrequency (RF) energy treatment (Stretta procedure) was evaluated on Improvement in heartburn scores, GERD-specific quality of life scores, and general quality of life scores at 24 and 48 months (p=0.001). Radiofrequency energy treatment significantly improved heartburn and GERD-specific quality of life scores at 48 months in 92.8% of patients, with 72.3% completely off PPIs.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: